您使用提示模式 关闭

XDNA - iShares Genomics Immunology and Healthcare Index ETF (CAD) (CA46437W1059)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
CA46437W1059
XDNA ISIN
交易所交易基金 (ETF)
基金类型
BlackRock
提供商
-
每股资产净值
2022-04-26
成立日期
2 每年的次数
股息的支付
CEOJLU
CFI
XDNA
代码
Formed
Status
Equity
投资项目
Healthcare
部门
Global
地区分布
NYSE FactSet Global Genomics and Immuno Biopharma Index
基准
0.39 %
总成本比率
Physical
复制方法
9,81 百万 CAD
基金资产总量 | 2026-07-10
9,81 百万 CAD
股票类资产 | 2026-07-10
UCITS

收益率 在 2026-07-13, Toronto SE

  • YTD
    9,51 %
  • 1M
    -7,03 %
  • 3M
    0,05 %
  • 6M
    9,54 %
  • 1Y
    46,69 %
  • 3Y
    21,12 %
  • 5Y
    -
  • 10Y
    -
按交换价格计算,包括收入支付

最新数据在
添加比较项目

报价 (XDNA)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件

价格动态的变化

Fund profile

The iShares Genomics Immunology and Healthcare Index ETF seeks to replicate as close as possible the price and yield performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

XDNA profile

The iShares Genomics Immunology and Healthcare Index ETF (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The BlackRock fund’s base currency is CAD and the share class was registered 26.04.2022 with unique ISIN - CA46437W1059. Main exchange is Toronto SE and ticker symbol is XDNA. The total expense ratio is 0.39%. The iShares Genomics Immunology and Healthcare Index ETF (CAD) pays dividends 2 time(s) per year.

结构 XDNA 在 2026-07-10

证券
MODERNA INC 5,04%
BAYER AG 4,8%
TWIST BIOSCIENCE CORP 4,59%
REVOLUTION MEDICINES INC 4,39%
GENMAB 4,04%
INCYTE CORP 4%
VERTEX PHARMACEUTICALS INC 3,8%
TAKEDA PHARMACEUTICAL LTD 3,78%
EXELIXIS INC 3,76%
REGENERON PHARMACEUTICALS INC 3,66%
BIONTECH SE ADR 3,64%
MERCK & CO INC 3,58%
IPSEN SA 3,57%
GLAXOSMITHKLINE 3,55%
ROCHE PS PAR AG 3,54%
IMMUNITYBIO INC 3,4%
SANOFI SA 3,38%
IDEAYA BIOSCIENCES INC 3,38%
ARCUS BIOSCIENCES INC 2,66%
CARIS LIFE SCIENCES INC 2,29%
ONO PHARMACEUTICAL LTD 1,86%
IOVANCE BIOTHERAPEUTICS INC 1,81%
ABCELLERA BIOLOGICS INC 1,75%
CRISPR THERAPEUTICS AG 1,68%
NOVAVAX INC 1,6%
NUVATION BIO INC CLASS A 1,58%
VIR BIOTECHNOLOGY INC 1,46%
CORVUS PHARMACEUTICALS INC 1,09%
KURA ONCOLOGY INC 1,08%
GENFLEET THERAPEUTICS (SHANGHAI) I 1,05%
JANUX THERAPEUTICS INC 1,03%
PERSONALIS INC 0,96%
SUNSHINE LAKE PHARMA LTD CLASS H 0,84%
RIGEL PHARMACEUTICALS INC 0,84%
CYTOMX THERAPEUTICS INC 0,72%
INTELLIA THERAPEUTICS INC 0,66%
DESIGN THERAPEUTICS INC 0,63%
OCUGEN INC 0,54%
SHANGHAI HENLIUS BIOTECH INC H 0,54%
VERASTEM INC 0,5%
PACIFIC BIOSCIENCES OF CALIFORNIA 0,49%
GINKGO BIOWORKS HOLDINGS INC CLASS 0,47%
VALNEVA 0,43%
ALVOTECH SA 0,41%
XENCOR INC 0,39%
ABCLON INC 0,27%
CAD CASH 0,15%
PRIME MEDICINE INC 0,13%
USD CASH 0,06%
JPY CASH 0,05%
GBP CASH 0,03%
EUR CASH 0,03%
DKK CASH 0,01%
CHF CASH 0,01%
HKD CASH 0,01%
ARCELLX INC CVR 0%
TWD CASH 0%
KRW CASH 0%
OMNIAB INC $12.50 VESTING Prvt 0%
OMNIAB INC $15.00 VESTING Prvt 0%
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权